Giuseppe Ciaramella, President & CSO at Beam Therapeutics Inc. (BEAM), sold 58,786 shares at $85.38 ($5.0M) on 2021-12-21, disclosed to the SEC on 2021-12-22.
Open-market sale of $5.0M BEAM by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.20 | 4,289 | $365K | 7.3% |
| 2 | $85.20 | 4,289 | $365K | 7.3% |
| 3 | $85.38 | 16,456 | $1.4M | 27.9% |
| 4 | $85.38 | 16,456 | $1.4M | 27.9% |
| 5 | $86.29 | 8,648 | $746K | 14.8% |
| 6 | $86.29 | 8,648 |
| $746K |
| 14.8% |
| Total | $85.62 avg | 58,786 | $5.0M | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |